zoledronic acid

Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
PR-USA
Sun, 05/23/10 - 12:07 pm
Amgen
denosumab
zoledronic acid
Bone metastases
prostate cancer